Sinonasal Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-07-10
Clinical Trial Update: Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS [Phase 1, Phase 2]
A Phase 1/2 study of frontline pembrolizumab plus valemetostat for PD-L1 positive, HPV-negative recurrent/metastatic squamous cell carcinoma…